Ridge Biotechnologies just raised. Here's exactly what to do next.
Who to reach, what to say, and why now — on Ridge Biotechnologies, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Everyone else gives you a piece
Only Fundz delivers all four.
Ridge Biotechnologies raises $25 million in seed financing to enhance AI-enabled precision enzyme and drug design, led by Sutter Hill Ventures.
Amount Raised
$25 Million
Round Type
seed
Investors
Description
Ridge Biotechnologies has emerged from stealth with an oversubscribed $25 million in seed financing. The round was led by Sutter Hill Ventures, with participation from Overlap Holdings. The funding will support the rollout of its NativeLink and ProTrigger products. Ridge Bio aims to develop cutting-edge therapeutics using machine learning and bioengineering.
Related People
Funding Insights
Based on industry dataWatching Ridge Biotechnologies? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan